Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction

Gut microbiome composition, a third player in the inflammation–arterial stiffness relationship

(2018) Stéphane Laurent et al.   EUROPEAN HEART JOURNAL

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator

(2018) Paul W. Armstrong et al.   JACC-Heart Failure

The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection

(2018) Ana Rita Castro et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Immune mechanisms in heart failure

(2017) Yingying Zhang et al.   EUROPEAN JOURNAL OF HEART FAILURE

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF

(2017) Ulrik M. Mogensen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure

(2016) Alberto Palazzuoli et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cachexia and right ventricular dysfunction in chronic heart failure: what is the chicken and what the egg?

(2016) Martin Bahls et al.   EUROPEAN HEART JOURNAL

Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure

(2016) Miroslava Valentova et al.   EUROPEAN HEART JOURNAL

The prognostic impact of uric acid in patients with severely decompensated acute heart failure

(2016) Hirotake Okazaki et al.   Journal of Cardiology

Pathogenic Gut Flora in Patients With Chronic Heart Failure

(2016) Evasio Pasini et al.   JACC-Heart Failure

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study

(2015) M. M. Givertz et al.   CIRCULATION

Innate Immunity and the Failing Heart

(2015) Douglas L. Mann   CIRCULATION RESEARCH

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction

(2015) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)

(2014) Burkert Pieske et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Endothelial Function and Oxidative Stress in Cardiovascular Diseases

(2009) Yukihito Higashi et al.   CIRCULATION JOURNAL

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

(2008) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study

(2007) Eric S. Williams et al.   EUROPEAN JOURNAL OF HEART FAILURE